TrialJournal of gastrointestinal cancer2024

A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer.

Jingquan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.